Evaluation of the Efficacy and Safety of Fosfomycin Plus Imipenem for the Treatment of Methicillin-resistant Staphylococcus Aureus (MRSA) Infective Endocarditis.

NCT00871104 Phase 4 COMPLETED

The study evaluates the efficacy and safety of fosfomycin and imipenem for the treatment of methicillin-resistant staphyloccocus aureus infective endocarditis in comparison to vancomycin, the standard therapy.

Details

Lead sponsor	Juan A. Arnaiz
Phase	Phase 4
Status	COMPLETED
Enrolment	50
Start date	2009-07
Completion	2015-04-15

Conditions

• Infective Endocarditis

Interventions

• Fosfomycin and imipenem
• Vancomycin

Primary outcomes

• Proportion of patients with negative blood cultures. — 7 days

Countries

Spain